Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 24816996)

2.

Atherogenic dyslipidaemic profiles associated with the development of Type 2 diabetes: a 3.1-year longitudinal study.

Hwang YC, Ahn HY, Yu SH, Park SW, Park CY.

Diabet Med. 2014 Jan;31(1):24-30. doi: 10.1111/dme.12278. Epub 2013 Jul 26.

PMID:
23819613
3.

Association of HDL-C and apolipoprotein A-I with the risk of type 2 diabetes in subjects with impaired fasting glucose.

Hwang YC, Ahn HY, Park SW, Park CY.

Eur J Endocrinol. 2014 Jul;171(1):137-42. doi: 10.1530/EJE-14-0195. Epub 2014 Apr 23.

4.

Lipid risk factors among elderly with normal fasting glucose, impaired fasting glucose and type 2 diabetes mellitus. The Italian longitudinal study on aging.

Noale M, Maggi S, Zanoni S, Limongi F, Zambon S, Crepaldi G.

Nutr Metab Cardiovasc Dis. 2013 Mar;23(3):220-6. doi: 10.1016/j.numecd.2011.06.004. Epub 2011 Sep 19.

PMID:
21937208
5.

Evaluation of serum biomarkers in nutritional disorders: glycated apolipoprotein B, fasting serum glucose, fructosamine, stable and labile glycated hemoglobin in diabetic and non-diabetic subjects.

De Michele G, Correale M, De Michele O, Guerra V, Mazzarelli R, Misciagna G.

Immunopharmacol Immunotoxicol. 2008;30(4):925-36. doi: 10.1080/08923970802337718 .

PMID:
18720163
6.

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes.

Taskinen MR, Barter PJ, Ehnholm C, Sullivan DR, Mann K, Simes J, Best JD, Hamwood S, Keech AC; FIELD study investigators.

Diabetologia. 2010 Sep;53(9):1846-55. doi: 10.1007/s00125-010-1806-9. Epub 2010 Jun 6.

PMID:
20526762
7.

Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study.

Salomaa VV, Tuomilehto J, Jauhiainen M, Korhonen HJ, Stengård J, Uusitupa M, Pitkanen M, Penttila I.

Diabetes Care. 1992 May;15(5):657-65.

PMID:
1516486
8.

Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.

Zhang J, Fan P, Liu H, Bai H, Wang Y, Zhang F.

Hum Reprod. 2012 Aug;27(8):2484-93. doi: 10.1093/humrep/des191. Epub 2012 Jun 6.

9.

[Prevalence of type II diabetes mellitus in population of Krakow].

Szurkowska M, Szybiński Z, Nazim A, Szafraniec K, Jedrychowski W.

Pol Arch Med Wewn. 2001 Sep;106(3):771-9. Polish.

PMID:
11928585
10.

Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.

Mora S, Rifai N, Buring JE, Ridker PM.

Circulation. 2008 Sep 2;118(10):993-1001. doi: 10.1161/CIRCULATIONAHA.108.777334. Epub 2008 Aug 18.

11.

Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.

Lemieux S, Bédard A, Piché MÈ, Weisnagel SJ, Corneau L, Bergeron J.

Clin Endocrinol (Oxf). 2011 Mar;74(3):340-5. doi: 10.1111/j.1365-2265.2010.03933.x.

PMID:
21092050
12.

Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?

Piché ME, Després JP, Pascot A, Nadeau A, Tremblay A, Weisnagel SJ, Bergeron J, Lemieux S.

Diabet Med. 2004 Jul;21(7):730-7.

PMID:
15209766
13.

Non-HDL-cholesterol in an adolescent diabetes population.

Kuryan RE, Jacobson MS, Frank GR.

J Clin Lipidol. 2014 Mar-Apr;8(2):194-8. doi: 10.1016/j.jacl.2013.12.006. Epub 2013 Dec 17.

PMID:
24636179
14.

The relationship between BMI and glycated albumin to glycated hemoglobin (GA/A1c) ratio according to glucose tolerance status.

Huh JH, Kim KJ, Lee BW, Kim DW, Kang ES, Cha BS, Lee HC.

PLoS One. 2014 Feb 28;9(2):e89478. doi: 10.1371/journal.pone.0089478. eCollection 2014.

15.

Dyslipidemia, metabolic syndrome, and liver enzymes in impaired glucose tolerance and new onset untreated, type 2 diabetes Indian subjects.

Sanyal D, Ghosh S, Mukherjee P, Mukherjee S, Chowdhury S.

Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S434-5. doi: 10.4103/2230-8210.104121.

16.

Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).

Chakarova N, Tankova T, Atanassova I, Dakovska L.

Diabetes Res Clin Pract. 2009 Oct;86(1):56-60. doi: 10.1016/j.diabres.2009.04.005. Epub 2009 Aug 11.

PMID:
19674805
17.

Non-high-density lipoprotein cholesterol is associated more closely with albuminuria in Chinese type 2 diabetic patients with normal renal function, compared with traditional lipid parameters.

Pan J, Gao F, Bao Y, Zhang L, Tu Y, Jia W.

J Clin Lipidol. 2012 Jul-Aug;6(4):382-7. doi: 10.1016/j.jacl.2012.01.008. Epub 2012 Jan 28.

PMID:
22836076
18.

Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N.

Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):334-9.

PMID:
15977101
19.
20.

Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial.

Wu L, Piotrowski K, Rau T, Waldmann E, Broedl UC, Demmelmair H, Koletzko B, Stark RG, Nagel JM, Mantzoros CS, Parhofer KG.

Metabolism. 2014 Mar;63(3):382-91. doi: 10.1016/j.metabol.2013.11.005. Epub 2013 Nov 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk